Abciximab use in specific populations: Difference between revisions

Jump to navigation Jump to search
(Created page with "__NOTOC__ {{Abciximab}} {{CMG}}; {{AE}} {{SS}}, {{PB}} <ref name="dailymed.nlm.nih.gov">{{Cite web | last = | first = | title = REOPRO (ABCIXIMAB) INJECTION, SOLUTION [E...")
 
 
Line 1: Line 1:
__NOTOC__
#REDIRECT [[Abciximab#Use in Specific Populations]]
{{Abciximab}}
{{CMG}}; {{AE}} {{SS}}, {{PB}}
 
 
 
<ref name="dailymed.nlm.nih.gov">{{Cite web  | last =  | first =  | title = REOPRO (ABCIXIMAB) INJECTION, SOLUTION [ELI LILLY AND COMPANY] | url = http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=033d4c3b-4630-4256-b8f7-9ed5f15de9a3#nlm34067-9 | publisher =  | date =  | accessdate = }}</ref>
 
==References==
{{Reflist}}
 
{{FDA}}
 
[[Category:Drugs]]

Latest revision as of 02:30, 22 July 2014